DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAGP

Distribution, configuration and surface change

Essential points for quick revision.

!
Escalate

Escalate urgently when assessment for Distribution, configuration and surface change reveals systemic toxicity, airway or eye involvement, extensive skin failure, a non-blanching eruption in an unwell patient, or a rapidly changing lesion suspicious for aggressive malignancy.

Synopsis

Use anatomical distribution, lesion configuration and surface change to narrow dermatological differentials while avoiding pattern labels that conceal incomplete examination.

  • Distribution records where lesions occur and where they are spared: flexural, extensor, acral, seborrhoeic, photodistributed, dermatomal, intertriginous or generalised.
  • Configuration describes relations between lesions, including annular, arcuate, linear, grouped, reticulate, targetoid, discoid and confluent patterns.
  • Inspect scalp, hair, nails, mucosae, palms, soles and skin folds when consented because hidden sites may separate close differentials.

Key red flags

Generalised skin pain, rapidly extending erythema, confluent purpura, mucosal loss, erythroderma or a dermatomal eruption affecting the eye requires urgent action.

Dermatomal grouping

Unilateral grouped vesicles with neuropathic pain in a sensory distribution supports herpes zoster, especially when lesions stop near the midline.

Investigation priorities

01
Complete distribution diagramFirst step

Capture involved and spared anatomy before treatment.

Management branches

Planned assessmentUse whole-skin pattern mapping systematically

The patient is stable and the result will alter diagnosis, referral or follow-up.

  1. Define the question for Distribution, configuration and surface change, explain the process and obtain valid consent before exposing, touching, photographing or sampling skin.
  2. Choose representative anatomy, optimise lighting or specimen technique, and document site, morphology, symptoms and relevant previous treatment. Apply that step specifically within the distribution, configuration and surface change assessment and its recorded clinical context.
Open full textbook Answer 2 questions
Sources and review status3 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom